Financials

  • Market Capitalization 72.53 M
  • Employee 13
  • Founded 2012
  • CEO N/A
  • Website www.atarabio.com
  • Headquarter Delaware, United States
  • FIGI BBG005Q3MQY4
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
7.04
Price to sales ratio
1.9

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4120
GANX
Gain Therapeutics, Inc. - Common Stock
1.69 USD-3.98%-6.63%-1.17%-9.14%72.09 M USD
4133
PMVP
PMV Pharmaceuticals, Inc. - Common Stock
1.43 USD+11.72%+15.32%+28.83%+7.52%76.26 M USD
4151
IBIO
iBio, Inc. - Common Stock
1.45 USD0.00%-8.81%-15.20%-36.96%72.03 M USD
4156
XBIT
XBiotech Inc. - Common Stock
2.29 USD-1.72%-2.55%-3.38%-21.03%69.82 M USD

Frequently asked questions about Atara Biotherapeutics, Inc. - Common Stock

What is the Atara Biotherapeutics, Inc. - Common Stock stock price today?

The current price of Atara Biotherapeutics, Inc. - Common Stock (ATRA) is 8.05. Over the past 24 hours, the stock has changed by -7.15%. Follow the ATRA chart for real-time price dynamics.

What is the stock ticker of Atara Biotherapeutics, Inc. - Common Stock?

Atara Biotherapeutics, Inc. - Common Stock trades under the ticker ATRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Atara Biotherapeutics, Inc. - Common Stock stock going up?

ATRA has changed by -21.54% over the last week, -23.33% over the last month, and -45.42% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Atara Biotherapeutics, Inc. - Common Stock net income for the last quarter?

Atara Biotherapeutics, Inc. - Common Stock reported net income of -4.14 M for the last quarter. The previous quarter showed -3.41 M, which means net income changed by -21.70%.

How many employees does Atara Biotherapeutics, Inc. - Common Stock have?

As of the latest available data, Atara Biotherapeutics, Inc. - Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.

What is Atara Biotherapeutics, Inc. - Common Stock EBITDA?

Atara Biotherapeutics, Inc. - Common Stock EBITDA is -3.36 M, and its EBITDA margin is -650.39%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Atara Biotherapeutics, Inc. - Common Stock stock?

You can buy Atara Biotherapeutics, Inc. - Common Stock (ATRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Atara Biotherapeutics, Inc. - Common Stock stock?

Investing in Atara Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ATRA chart and related analysis on metatrader.com as part of your research.

News